Wakix (pitolisant) — Medica

Preferred products

• generic modafinil
• generic armodafinil
• CNS stimulant (e.g., methylphenidate, dexmethylphenidate, dextroamphetamine)

Initial criteria

• Patient is age ≥ 6 years
• Patient has been evaluated using polysomnography and a multiple sleep latency test
• Diagnosis of narcolepsy has been confirmed by the prescriber
• Medication is prescribed by or in consultation with a sleep specialist physician or a neurologist
• Patient has tried at least ONE of the following: a central nervous system (CNS) stimulant (e.g., methylphenidate, dexmethylphenidate, dextroamphetamine), generic modafinil, or generic armodafinil, OR patient has a history of substance use disorder and a non-controlled wakefulness-promoting agent is necessary
• Do not use concomitantly with an oxybate product or Sunosi (solriamfetol)

Reauthorization criteria

• Diagnosis of narcolepsy with excessive daytime sleepiness remains confirmed and treatment continues to be prescribed by or in consultation with a sleep specialist or neurologist

Approval duration

1 year